Professional Documents
Culture Documents
^(ValidationDate)
Yes
1
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 1/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
4.2 Most important symptoms and effects, both acute and delayed
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 3/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Exposure to component solvent vapour concentrations in excess of the stated occupational exposure limit may result
in adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Based on the properties of the epoxy constituent(s) and considering toxicological data on similar mixtures, this
mixture may be a skin sensitiser and an irritant. It contains low molecular weight epoxy constituents which are
irritating to eyes, mucous membrane and skin. Repeated skin contact may lead to irritation and to sensitisation,
possibly with cross-sensitisation to other epoxies. Skin contact with the mixture and exposure to spray mist and
vapour should be avoided.
4.3 Indication of any immediate medical attention and special treatment needed
Notes to physician : In case of inhalation of decomposition products in a fire, symptoms may be delayed.
The exposed person may need to be kept under medical surveillance for 48 hours.
Specific treatments : No specific treatment.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 4/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
6.2 Environmental : Avoid dispersal of spilt material and runoff and contact with soil, waterways, drains
precautions and sewers. Inform the relevant authorities if the product has caused environmental
pollution (sewers, waterways, soil or air). Water polluting material. May be harmful
to the environment if released in large quantities. Collect spillage.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 5/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 6/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 7/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
For right choice of glove materials, with focus on chemical resistance and time of penetration, seek advice by the
supplier of chemical resistant gloves.
The user must check that the final choice of type of glove selected for handling this product is the most
appropriate and takes into account the particular conditions of use, as included in the user's risk assessment.
Body protection : Personal protective equipment for the body should be selected based on the task
being performed and the risks involved and should be approved by a specialist
before handling this product.
Other skin protection : Appropriate footwear and any additional skin protection measures should be
selected based on the task being performed and the risks involved and should be
approved by a specialist before handling this product.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 8/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 9/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Exposure to component solvent vapour concentrations in excess of the stated occupational exposure limit may result
in adverse health effects such as mucous membrane and respiratory system irritation and adverse effects on the
kidneys, liver and central nervous system. Symptoms and signs include headache, dizziness, fatigue, muscular
weakness, drowsiness and, in extreme cases, loss of consciousness.
Solvents may cause some of the above effects by absorption through the skin. Repeated or prolonged contact with
the mixture may cause removal of natural fat from the skin, resulting in non-allergic contact dermatitis and absorption
through the skin.
If splashed in the eyes, the liquid may cause irritation and reversible damage.
This takes into account, where known, delayed and immediate effects and also chronic effects of components from
short-term and long-term exposure by oral, inhalation and dermal routes of exposure and eye contact.
Based on the properties of the epoxy constituent(s) and considering toxicological data on similar mixtures, this
mixture may be a skin sensitiser and an irritant. It contains low molecular weight epoxy constituents which are
irritating to eyes, mucous membrane and skin. Repeated skin contact may lead to irritation and to sensitisation,
possibly with cross-sensitisation to other epoxies. Skin contact with the mixture and exposure to spray mist and
vapour should be avoided.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 10/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 11/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
The mixture has been assessed following the summation method of the CLP Regulation (EC) No 1272/2008 and is
classified for eco-toxicological properties accordingly. See Sections 2 and 3 for details.
Product/ingredient name Result Species Exposure
epoxy resin (MW ≤ 700) Acute EC50 1.4 mg/l Daphnia 48 hours
Acute LC50 3.1 mg/l Fish - pimephales promelas 96 hours
Chronic NOEC 0.3 mg/l Fish 21 days
oxirane, 2,2'- Acute EC50 47 mg/l Daphnia 48 hours
[1,6-hexanediylbis
(oxymethylene)]bis-
Acute LC50 30 mg/l Fish - Cyprinidae (Leuciscus 96 hours
idus)
Conclusion/Summary : Water polluting material. May be harmful to the environment if released in large
quantities. This material is toxic to aquatic life with long lasting effects.
12.2 Persistence and degradability
Conclusion/Summary : Not available.
Product/ingredient name Aquatic half-life Photolysis Biodegradability
epoxy resin (MW ≤ 700) - - Not readily
silane, trimethyoxy[3- - - Not readily
(oxiranyl-methoxy)propyl]-
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 12/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 13/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
14.6 Special precautions for : Transport within user’s premises: always transport in closed containers that are
user upright and secure. Ensure that persons transporting the product know what to do in
the event of an accident or spillage.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 14/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
15.2 Chemical safety : This product contains substances for which Chemical Safety Assessments are still
assessment required.
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 15/16
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by UK REACH Regulation SI 2019/758
Marathon 1000 XHB Comp A
Date of issue/Date of revision : 21.04.2023 Date of previous issue : 30.03.2023 Version : 1.02 16/16